शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BLUEJETBSEBLUE JET HEALTHCARE LTD· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 3 Aug, 2026 · 12:44 IST

Q1 FY27 results, director re-appointments, Rs 1.2 dividend record date

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.8%Reaction day
₹625.00
prior close
₹641.95
announcement price
In-mkt
timing
Nifty Smallcap 250market+1.4%-7.2% vs market
Pharmaceuticals peers, median of 163sector+1.0%-6.8% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Smallcap 250 and 6.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-9.8
10m
-7.0
15m
-8.4
30m
-6.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.8+1.4-7.2+1.0-6.8
Next day
-6.7+1.5-8.3+0.8-7.5
2d
-4.8+2.2-7.0+0.3-5.1
3d
-5.9+2.4-8.4+0.7-6.7
4d
-5.1+2.4-7.6+1.5-6.6
5d
-5.3+2.4-7.7+1.3-6.6
1w
-5.9+2.3-8.2+1.6-7.6
15d
-5.4+2.5-8.0+0.9-6.3
1m
-7.5+2.9-10.4+1.7-9.2
2m
-14.8-1.5-13.3+1.9-16.7
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 standalone results with revenue from operations at Rs 2,931 million, down from Rs 3,548 million in Q1 FY26. Net profit fell to Rs 783 million from Rs 912 million. EPS stood at Rs 4.51. The Board reappointed Mr. Akshay B Arora as Executive Chairman and Mr. Shiven Akshay Arora as Managing Director for five years from April 13, 2027, and reappointed KKC and Associates as statutory auditors for a second five-year term. Record date for Rs 1.2 per share dividend is September 14, 2026. 58th AGM on September 21, 2026.

Likely market impact

Revenue and profit declined year-on-year in Q1. Director continuity provides stability. Dividend record date set for September 14.